Brought to you by 
Gilead and Galapagos announce major multi-project collaboration
27 Aug 2019
Executive Summary
Rather than buying the company outright, Gilead Sciences Inc. has decided to continue its R&D relationship with Galapagos NV through a new collaboration that gives Gilead access to all of the projects in Galapagos’ pipeline.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Includes Royalty or Profit Split Information
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com